Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Clinical trial NCT02401542 · TERMINATED
Trial details
- NCT number
- NCT02401542
- Sponsor
- Rainier Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2019-11-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.